Liver

Nonalcoholic steatohepatitis (NASH) emerges as a critical health issue linked to obesity and metabolic disorders, with alarming progression to cirrhosis or liver cancer. This comprehensive guide explores the diagnosis, lifestyle changes, medical treatments, and supportive therapies available for managing NASH, drawing attention to effective strategies and future therapies. Understanding NASH Liver Disease Nonalcoholic steatohepatitis (NASH) […]

Ocaliva, or Obeticholic Acid, emerges as a promising therapy for non-alcoholic steatohepatitis (NASH), focusing on improving liver fibrosis in this severe condition. The importance of targeting fibrosis is underscored by NASH’s chronic progression towards cirrhosis and liver failure. Insights from pivotal studies illustrate Ocaliva’s effectiveness, highlighting its dosage-related benefits and manageable safety profile. The Role […]

Nonalcoholic Steatohepatitis (NASH) stands as a formidable progression of Nonalcoholic Fatty Liver Disease (NAFLD), posing significant challenges due to its silent nature and potential for severe liver complications. While lifestyle changes remain pivotal in management, advancements in medication and research offer promising avenues for treatment. Understand the critical aspects of NASH, its treatments, and the […]